In a defining moment for global agri-science and Indian biotechnology, the country has launched its first genome-edited rice varieties—DRR Dhan 100 (Kamala) and Pusa DST Rice 1—heralding what policymakers and scientists alike are calling a second green revolution. Developed using CRISPR-Cas9 precision gene-editing tools under the SDN1 and SDN2 categories, these rice strains represent a paradigm shift in crop improvement—achieving genetic enhancement without introducing foreign DNA. The distinction not only separates them from traditional GMOs but also positions India at the global forefront of sustainable agricultural innovation.
At the heart of this achievement are the Indian Council of Agricultural Research’s premier institutions—ICAR-IIRR (Hyderabad) and ICAR-IARI (New Delhi). These institutes took two widely accepted and traditionally cultivated rice varieties—Samba Mahsuri (BPT-5204) and MTU 1010—and elevated their agronomic potential. The result: rice strains that yield 20–30% more, consume less water, mature faster, and exhibit resistance to drought and salinity. Kamala, for instance, matures 20 days earlier and can save 7,500 million cubic meters of irrigation water by reducing three irrigation cycles. When scaled across 5 million hectares, the impact translates to an additional 4.5 million tonnes of paddy and up to 20% lower methane emissions—a massive stride in climate-smart agriculture.
Importantly, these genome edits were made using India’s relaxed regulatory provisions for non-transgenic crops. In 2022, India officially exempted SDN1 and SDN2 crops—those that don’t carry foreign genes—from the stringent GMO oversight norms, facilitating faster translation of lab breakthroughs to the field. This regulatory clarity paved the way for these varieties to be classified and cleared by May 2023, opening the door for eventual nationwide rollout.
But the road ahead isn’t without challenges. Environmental and food safety advocates, especially the “Coalition for a GM-Free India,” have raised concerns around biosafety, ecological impacts, and seed sovereignty. They’ve questioned the adequacy of India’s current regulatory framework and drawn uneasy parallels with past controversies surrounding Bt cotton and GM brinjal. Additionally, India’s reliance on patented CRISPR-Cas9 technology, owned by firms like ERS Genomics, introduces a layer of IPR complexity. The lack of indigenous alternatives risks high licensing costs that could trickle down to farmers—unless strategic negotiations or a proposed “One Nation, One License” policy becomes operational.
Despite this, the national vision remains ambitious. These rice varieties are only the beginning; over 24 food crops and 15 horticultural crops are currently in the ICAR genome-editing pipeline. Moreover, with the appointment of Dr. Himanshu Pathak as the first Indian Director General of ICRISAT, India is not only fortifying domestic food security but also reshaping global agri-diplomacy. Through initiatives like the ICRISAT Centre of Excellence for South-South Cooperation in Agriculture, India is actively transferring innovations, policy models, and peer-to-peer learning platforms to the Global South.
This moment in Indian agriculture is not just about scientific prowess; it’s about vision—leveraging biotechnology to address climate change, elevate smallholder resilience, reduce environmental footprint, and reclaim leadership in sustainable food systems. As the globe watches closely, India’s genome-edited rice fields may well become the blueprint for a more equitable, efficient, and ecologically balanced future.
-Srujan Punna
